Starpharma Holdings Limited
SPHRY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $36,221 | $43,102 | $36,776 | $74,770 |
| - Cash | $15,407 | $20,277 | $23,360 | $32,131 |
| + Debt | $2,402 | $2,475 | $3,528 | $3,129 |
| Enterprise Value | $23,216 | $25,300 | $16,944 | $45,768 |
| Revenue | $1,712 | $2,427 | $1,731 | $7,197 |
| % Growth | -29.5% | 40.2% | -75.9% | – |
| Gross Profit | -$736 | -$2,258 | -$3,490 | $6,427 |
| % Margin | -43% | -93% | -201.6% | 89.3% |
| EBITDA | -$2,235 | -$5,254 | -$6,983 | -$2,649 |
| % Margin | -130.6% | -216.5% | -403.4% | -36.8% |
| Net Income | -$2,299 | -$5,392 | -$7,131 | -$1,034 |
| % Margin | -134.3% | -222.2% | -412% | -14.4% |
| EPS Diluted | -0.055 | -0.13 | -0.17 | -0.025 |
| % Growth | 57.7% | 23.5% | -580% | – |
| Operating Cash Flow | -$2,382 | -$998 | -$9,075 | $2,098 |
| Capital Expenditures | -$6 | -$16 | -$80 | -$9 |
| Free Cash Flow | -$2,387 | -$1,014 | -$9,155 | $2,089 |